Tag Archives: CBLI

Top 10 Casino Stocks To Own For 2019

We already hit an 82% winner from gambling stocks, and we’re going to share another potential profit opportunity in just a bit.

But first, let’s start with some major news about a new collaboration…

Las Vegas casino operator Boyd Gaming Corp. (NYSE: BYD) just signed a strategic partnership with FanDuel, a popular online fantasy sports gaming site. FanDuel and Boyd will explore sports betting and online gaming opportunities across the country.

Boyd Gaming is a leader in the gaming industry, and once it completes two acquisitions, it will operate 29 casinos across 10 states.

Top 10 Casino Stocks To Own For 2019: Nabors Industries Ltd.(NBR)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Nabors Industries (NBR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Nabors Industries (NYSE:NBR) was the recipient of a significant drop in short interest in April. As of April 30th, there was short interest totalling 39,104,204 shares, a drop of 6.2% from the April 13th total of 41,702,268 shares. Currently, 11.5% of the shares of the stock are short sold. Based on an average trading volume of 6,716,985 shares, the days-to-cover ratio is presently 5.8 days.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Nabors Industries (NBR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Dan Caplinger]

    The stock market had a mildly positive day on Friday, and gains of between 0.1% and 0.3% were common for most of the major benchmark indexes. Without any outright hostility among leaders of the G-7 nations in their summit in Canada’s Quebec City, investors seemed content to go into the weekend with confidence in the prospects for the U.S. economy and its biggest businesses. Yet some individual companies had bad news that held their shares back from participating in the rally. Nabors Industries (NYSE:NBR), PolarityTE (NASDAQ:COOL), and Evolus (NASDAQ:EOLS) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 Casino Stocks To Own For 2019: Canadian National Railway Company(CNI)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    In this segment, Brendan Mathews — a member of the Stock Advisor research team, and the portfolio lead for Odyssey 2 and Supernova — talks about the lessons one can learn from the tale of Canadian National(NYSE:CNI), a Stock Advisor recommendation since 2008. One might expect a railroad company to be a steady, predictable performer, but its stock chart looks more like a roller coaster over that period. (And, as a bonus, they also chat a bit about the story of salesforce.com(NYSE:CRM), so stick around to the end.)

  • [By Max Byerly]

    Here are some of the headlines that may have effected Accern Sentiment Analysis’s rankings:

    Get Canadian National Railway alerts:

    Keep an eye on Price Trends: Canadian National Railway Company (CNI), Telephone and Data Systems, Inc. (TDS) (talktraders.com) Amtrak study could help trains run on time (whig.com) Canadian National Railway Is Regaining Momentum (seekingalpha.com) JetBlue Announces Ratification of 4-Year Pilot Contract (finance.yahoo.com) Norfolk Southern Rewards Shareholders With 11% Dividend Hike (finance.yahoo.com)

    Several research firms have recently weighed in on CNI. Zacks Investment Research upgraded Canadian National Railway from a “hold” rating to a “buy” rating and set a $101.00 price target for the company in a research note on Monday. CIBC downgraded Canadian National Railway from a “sector outperform” rating to a “sector perform” rating in a research note on Tuesday, May 1st. Cowen reiterated a “buy” rating and set a $98.00 price target on shares of Canadian National Railway in a research note on Wednesday, July 25th. Goldman Sachs Group downgraded Canadian National Railway from a “buy” rating to a “neutral” rating and set a $102.00 price target for the company. in a research note on Monday, May 14th. Finally, Citigroup increased their price target on Canadian National Railway from $85.00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 25th. Thirteen equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Canadian National Railway currently has an average rating of “Hold” and a consensus target price of $89.98.

  • [By Paul Ausick]

    GE got some good news this past week with an order for 200 locomotives from Canadian National Railway Co. (NYSE: CNI). The locomotives will be built at GE’s plant in Fort Worth, Texas, and deliveries to the rail operator will begin next year. The balance of the locomotives will be delivered in 2019 and 2020.

  • [By Neha Chamaria]

    Canadian National Railway (NYSE:CNI) is facing a unique problem: too much demand that it can’t seem to handle. Severe capacity shortages and delay in deliveries last quarter proved costly for the railroad, as evidenced by its just released first-quarter earnings report.

Top 10 Casino Stocks To Own For 2019: Sims Metal Management Limited(SMS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Speed Mining Service (CURRENCY:SMS) traded 4.2% higher against the dollar during the 24 hour period ending at 0:00 AM E.T. on May 20th. One Speed Mining Service token can now be purchased for $16.33 or 0.00192074 BTC on cryptocurrency exchanges including CoinExchange and HitBTC. Speed Mining Service has a market capitalization of $1.71 million and $413.00 worth of Speed Mining Service was traded on exchanges in the last 24 hours. Over the last seven days, Speed Mining Service has traded 4.2% lower against the dollar.

  • [By Stephan Byrd]

    Speed Mining Service (CURRENCY:SMS) traded 7.8% lower against the US dollar during the 24 hour period ending at 8:00 AM Eastern on June 7th. During the last seven days, Speed Mining Service has traded 21.8% lower against the US dollar. One Speed Mining Service token can currently be bought for approximately $11.56 or 0.00150095 BTC on major exchanges including CoinExchange and HitBTC. Speed Mining Service has a market capitalization of $1.21 million and $182.00 worth of Speed Mining Service was traded on exchanges in the last 24 hours.

Top 10 Casino Stocks To Own For 2019: Cleveland BioLabs, Inc.(CBLI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Senomyx (NASDAQ: SNMX) and Cleveland BioLabs (NASDAQ:CBLI) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation.

  • [By Max Byerly]

    EXACT Sciences (NASDAQ: EXAS) and Cleveland BioLabs (NASDAQ:CBLI) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends.

Top 10 Casino Stocks To Own For 2019: Nevro Corp.(NVRO)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Wells Fargo & Company MN lessened its holdings in Nevro (NYSE:NVRO) by 5.2% during the first quarter, HoldingsChannel.com reports. The fund owned 823,579 shares of the medical equipment provider’s stock after selling 45,510 shares during the quarter. Wells Fargo & Company MN’s holdings in Nevro were worth $71,378,000 at the end of the most recent quarter.

  • [By Paul Ausick]

    Nevro Corp. (NYSE: NVRO) traded down about 19% Friday and posted a new 52-week low of $54.87 after closing Thursday at $68.04. The stock’s 52-week high is $94.34. Volume totaled around 5.7 million, close to 15 times the daily average. The company had no specific news.

  • [By Brian Feroldi]

    After reporting first-quarter results,shares in Nevro Corp. (NYSE:NVRO),a medical device maker that is focused onpain management, fell 15% as of 10:58 a.m. EDT on Tuesday.

  • [By Ethan Ryder]

    Nevro (NYSE:NVRO) had its price objective cut by Canaccord Genuity from $110.00 to $102.00 in a note issued to investors on Tuesday, Marketbeat Ratings reports. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. Canaccord Genuity’s price target indicates a potential upside of 34.87% from the stock’s current price.

  • [By Logan Wallace]

    Nevro (NYSE:NVRO) released its quarterly earnings results on Monday. The medical equipment provider reported ($0.59) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.32) by ($0.27), Bloomberg Earnings reports. Nevro had a negative net margin of 11.22% and a negative return on equity of 15.01%.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Nevro Corp. (NASDAQ: NVRO) fell 11.6 percent to $81.58 in pre-market trading after reporting wider-than-expected Q1 loss.
    Hertz Global Holdings, Inc. (NYSE: HTZ) shares fell 8.3 percent to $20.33 in pre-market trading after the company reported a wider-than-expected loss for its first quarter.
    Zillow Group, Inc. (NASDAQ: Z) fell 7.5 percent to $51.74 in pre-market trading. Zillow reported upbeat earnings for its first quarter, but issued weak sales guidance for the second quarter.
    Sanchez Energy Corporation (NYSE: SN) fell 7.2 percent to $3.11 in pre-market trading after reporting wider-than-expected Q1 loss.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 5.5 percent to $4.14 in pre-market trading after rising 11.17 percent on Monday.
    Albemarle Corporation (NYSE: ALB) fell 5.1 percent to $95.00 in pre-market trading. Albemarle declared a quarterly dividend of $0.335 per share.
    Tata Motors Limited (NYSE: TTM) fell 4.8 percent to $23.80 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) fell 4.5 percent to $57.14 in pre-market trading after reporting Q1 results.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares fell 4.3 percent to $2.25 in pre-market trading after gaining 1.73 percent on Monday.
    51job, Inc. (NASDAQ: JOBS) shares fell 4.2 percent to $93 in pre-market trading after rising 3.55 percent on Monday

Top 10 Casino Stocks To Own For 2019: Eagle Materials Inc(EXP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Despite some weather issues during the quarter, Eagle Materials (NYSE:EXP) finished its fiscal year on a positive note and delivered record revenue. That solid finish enabled the diversified materials producer to set full-year records for both sales and earnings. Meanwhile, with a strong balance sheet and some tailwinds at its back, the company sees even better days ahead.

  • [By Logan Wallace]

    Cementos Pacasmayo (NYSE: CPAC) and Eagle Materials (NYSE:EXP) are both construction companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation.

  • [By Stephan Byrd]

    Eagle Materials (NYSE:EXP) – Analysts at Northcoast Research issued their Q1 2019 earnings per share (EPS) estimates for shares of Eagle Materials in a research note issued to investors on Thursday, May 17th. Northcoast Research analyst K. Hocevar anticipates that the construction company will post earnings of $1.53 per share for the quarter. Northcoast Research also issued estimates for Eagle Materials’ Q2 2019 earnings at $1.80 EPS, Q3 2019 earnings at $1.70 EPS, Q4 2019 earnings at $1.17 EPS and FY2020 earnings at $7.40 EPS.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Home Depot Inc (NYSE: HD) to report quarterly earnings at $2.06 per share on revenue of $25.22 billion before the opening bell. Home Depot shares fell 0.04 percent to $191.00 in after-hours trading.
    Switch Inc (NYSE: SWCH) reported weaker-than-expected earnings for its first quarter on Monday. Switch shares dropped 7.18 percent to $14.36 in the after-hours trading session.
    Analysts are expecting Boot Barn Holdings, Inc. (NYSE: BOOT) to have earned $0.16 per share on revenue of $163.65 million in the latest quarter. Boot Barn will release earnings after the markets close. Boot Barn shares gained 1.4 percent to $21.80 in after-hours trading.
    Famous Dave’s of America, Inc. (NASDAQ: DAVE) reported upbeat earnings for its first quarter on Monday. Famous Dave’s of America shares gained 7.69 percent to $8.40 in the after-hours trading session.
    Before the markets open, Eagle Materials Inc (NYSE: EXP) is estimated to report quarterly earnings at $1.08 per share on revenue of $306.04 million. Eagle Materials shares fell 0.09 percent to $105.72 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 10 Casino Stocks To Own For 2019: Enbridge Inc(ENB)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    McDermott International, Inc. (NYSE: MDR) rose 19 percent to $7.20 in pre-market trading. Subsea 7 S.A. confirmed a $7.00 per share proposal to acquire McDermott.
    Clarus Corporation (NASDAQ: CLAR) rose 18.5 percent to $8.00 in pre-market trading.
    Enbridge Inc. (NYSE: ENB) rose 9.3 percent to $34.09 in pre-market trading after falling 2.41 percent on Friday.
    Lannett Company, Inc. (NYSE: LCI) rose 8.4 percent to $18 in pre-market trading. Lannett named Maureen M. Cavanaugh as senior vice president and chief commercial operations officer.
    Navios Maritime Midstream Partners L.P. (NYSE: NAP) rose 7.1 percent to $4.55 in pre-market trading after gaining 11.26 percent on Friday.
    Corcept Therapeutics Incorporated (NASDAQ: CORT) rose 6.9 percent to $18.80 in pre-market trading after falling 3.19 percent on Friday.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) rose 5.7 percent to $2.40 in pre-market trading after falling 10.98 percent on Friday.
    Vectren Corporation (NYSE: VVC) shares rose 5.6 percent to $69.20 in pre-market trading. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash
    Genprex, Inc. (NASDAQ: GNPX) shares rose 5.2 percent to $4.50 in pre-market trading.
    Atossa Genetics Inc. (NASDAQ: ATOS) rose 5.1 percent to $3.70 in pre-market trading after declining 19.35 percent on Friday.
    Sangamo Therapeutics, Inc. (NASDAQ: SGMO) shares rose 5 percent to $20 in pre-market trading.
    Magellan Midstream Partners, L.P. (NYSE: MMP) shares rose 5 percent to $68.41 in pre-market trading.
    Halozyme Therapeutics, Inc. (NASDAQ: HALO) shares rose 4.9 percent to $19.78 in the pre-market trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Matthew DiLallo]

    Several high-yielding dividend stocks have taken it on the chin this year due to a sell-off in the stock market and rising interest rates. That one-two punch has hit pipeline stocks the hardest, with several top-notch companies tumbling by a double-digit percentage since the start of the year. Three that stand out as excellent options to consider buying now that they’re on sale are Magellan Midstream Partners (NYSE:MMP), Antero Midstream Partners (NYSE:AM), and Enbridge (NYSE:ENB).

  • [By Shane Hupp]

    Shares of Enbridge Inc (TSE:ENB) (NYSE:ENB) reached a new 52-week high during mid-day trading on Thursday after GMP Securities raised their price target on the stock from C$55.00 to C$57.00. The company traded as high as C$47.50 and last traded at C$46.67, with a volume of 2103786 shares changing hands. The stock had previously closed at C$46.84.

Top 10 Casino Stocks To Own For 2019: Salesforce.com Inc(CRM)

Advisors’ Opinion:

  • [By Danny Vena]

    There was a lot to like when Salesforce.com (NYSE:CRM) reported its first-quarter financial results. The company delivered another impressive quarter, exceeding expectations and increasing its forecast for the full year.

  • [By Harsh Chauhan]

    AI is going to revolutionize customer relationship management (CRM), and there aren’t many better bets than Salesforce.com to tap into this. The company forecasts that spendingon AI deployment in CRM could jump from $7.9 billion in 2016 to as much as $46.3 billion in 2021.

  • [By Leo Sun]

    Veeva provides cloud-based customer relationship management (CRM) services for healthcare companies. Its core products include the Veeva Vault, which tracks prescribing habits, clinical trials, and industry regulations; and the Veeva Commercial Cloud, which helps drug companies maintain customer relationships.

  • [By Daniel Sparks]

    Amid the S&P 500’s nearly 5% gain over the past six months, one subsector has done exceptionally well: software-as-a-service (SaaS) stocks, particularly those providing platforms and applications to help businesses. The market seems head over heels for these stocks. Cloud-based customer relationship management companysalesforce.com(NYSE:CRM), financial software companyIntuit(NASDAQ:INTU), e-commerce platformShopify (NYSE:SHOP), and payment processor Square(NYSE:SQ) have all soared 30% or more during the last six months alone.

Top 10 Casino Stocks To Own For 2019: Entergy Louisiana, Inc.(ELA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Elastos (CURRENCY:ELA) traded down 2.3% against the dollar during the 1-day period ending at 20:00 PM E.T. on June 19th. Elastos has a market capitalization of $150.76 million and approximately $6.03 million worth of Elastos was traded on exchanges in the last day. In the last seven days, Elastos has traded 6.9% lower against the dollar. One Elastos coin can currently be bought for $28.91 or 0.00428971 BTC on major exchanges including Huobi and BCEX.

Top 10 Casino Stocks To Own For 2019: AVEO Pharmaceuticals, Inc.(AVEO)

Advisors’ Opinion:

  • [By Shane Hupp]

    AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO)’s share price traded down 24.2% during mid-day trading on Tuesday . The company traded as low as $2.15 and last traded at $2.16. 9,547,354 shares traded hands during trading, an increase of 395% from the average session volume of 1,930,275 shares. The stock had previously closed at $2.85.

  • [By Joseph Griffin]

    These are some of the media headlines that may have impacted Accern’s scoring:

    Get AVEO Pharmaceuticals alerts:

    Deadline Upcoming in $15 Million Settlement in the AVEO Pharmaceuticals Inc (NASDAQ:AVEO) Investor Lawsuit (digitaljournal.com) $1.35 Million in Sales Expected for AVEO Pharmaceuticals, Inc. (AVEO) This Quarter (americanbankingnews.com) AVEO Pharmaceuticals, Inc. (AVEO) Expected to Announce Earnings of -$0.06 Per Share (americanbankingnews.com) Equity Opportunities Iv Growth Purchases 236,479 Shares of AVEO Pharmaceuticals, Inc. (AVEO) Stock (americanbankingnews.com) AVEO Pharmaceuticals, Inc. (AVEO) Major Shareholder Buys $392,301.27 in Stock (americanbankingnews.com)

    Several analysts recently weighed in on the company. Zacks Investment Research raised AVEO Pharmaceuticals from a “strong sell” rating to a “hold” rating in a research note on Friday, May 4th. BidaskClub raised AVEO Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research note on Saturday, March 24th. Finally, ValuEngine raised AVEO Pharmaceuticals from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $4.05.

  • [By Brian Orelli]

    Shares of AVEO Pharmaceuticals (NASDAQ:AVEO) are down 17.9% at 11:58 a.m. EDT after the company issued an 8-K with the Securities and Exchange Commissionthat disclosed a settlement of a five-year-old class action lawsuit brought on by shareholders. Hidden 12 paragraphs into the document, AVEO Pharmaceuticals also disclosed that data for its phase 3 TIVO-3 trial will be delayed until the fourth quarter.

  • [By Maxx Chatsko]

    Shares of AVEO Pharmaceuticals (NASDAQ:AVEO) fell 17% today after the company announced first-quarter 2018 results and provided a business update. As a development stage biopharma company, there’s wasn’t much in the way of new financial details. However, the company did announce that it was delaying the expected readout of top-line data from the ongoing phase 3 trial of its lead drug candidate from the second quarter of 2018 to the third quarter of 2018.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on AVEO Pharmaceuticals (AVEO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Medical Stocks To Buy For 2019

The pain in her legs was so unbearable that she couldn’t muster one more step… let alone the dozen or so needed to make it to her sorority just down the street. She had to call a friend to pick her up.

Nicole Labonte didn’t know what was happening. But this was the first sign that something was clearly wrong, and she needed to see a doctor immediately. A trip to the health center revealed that her blood pressure was astronomically high. After several tests, they finally diagnosed Nicole with a rare vascular disease called Takayasu arteritis, which causes inflammation of the largest blood vessel in the body, the aorta, and its branches.

Vascular diseases, like the one Nicole was diagnosed with, can be difficult to detect. Diseases can appear anywhere in the body in many different forms. In fact, John Hopkins Medical Center estimates that 78 million Americans have the most common form… high blood pressure.

Hot Medical Stocks To Buy For 2019: Jacobs Engineering Group Inc.(JEC)

Advisors’ Opinion:

  • [By ]

    Jacobs Engineering (NYSE: JEC) recently closed its $3.3 billion acquisition of CH2M, which gives the firm a scale advantage in environmental cleanup and increases its capabilities across infrastructure. Jacobs is particularly strong in the aerospace and technology segment, closing multi-year awards last year for NASA and the Missile Defense Agency.

  • [By Ben Levisohn]

    Lee offers 22 stocks that could benefit from the correlation trade: Western Digital (WDC), Xerox (XRX), First Solar, Ford Motor, Best Buy (BBY), PulteGroup (PHM), AutoNation (AN), Textron (TXT), Jacobs Engineering Group (JEC), Mosaic, BB&T (BBT), Fifth Third Bancorp (FITB),Loews (L), Regions Financial (RF), KeyCorp (KEY), Comerica (CMA), Leucadia National (LUK), Zions Bancorp (ZION), Valero Energy (VLO), Marathon Oil, Cardinal Health (CAH), and Pepco Holdings (POM).

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was Jacobs Engineering Group Inc. (NYSE: JEC) which rose about 9% to $64.92. The stocks 52-week range is $49.31 to $65.29. Volume was1.8 million compared to its average volume of less than 1 million.

Hot Medical Stocks To Buy For 2019: Enerplus Corporation(ERF)

Advisors’ Opinion:

  • [By Money Morning News Team]

    Enerplus Corp. (NYSE: ERF) is a $2.1 billion oil company based in Calgary and trades on both the NYSE and Toronto Stock Exchange. ERF primarily produces crude oil in the Bakken fields in North Dakota and Western Canada.

Hot Medical Stocks To Buy For 2019: Cleveland BioLabs, Inc.(CBLI)

Advisors’ Opinion:

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Lisa Levin]

    In trading on Tuesday, healthcare shares fell by 0.98 percent. Meanwhile, top losers in the sector included Cleveland BioLabs, Inc. (NASDAQ: CBLI), down 25 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI), down 8 percent.

  • [By Alex McGuire]

    You see, penny stocks are attractive because they can offer double-digit or even triple-digit returns in a very short time. For example, Cleveland BioLabs Inc. (Nasdaq: CBLI) skyrocketed from $1.56 at the Thursday, April 13, close to $5.10 on Wednesday, April 19. That’s a stunning 227% return in just three sessions (the markets were closed that Friday).